Skip to main content

Falcon Genomics, Inc.

An eye on functional genomics as a tool for cancer diagnostics and therapeutics.
Contact Us
Site Map
Member Login
The Cancer BioChip System
CBCS Services
Affymetrix GeneAtlas Serv
Falcon Genomics Brochure
Falcon Breast Cancer Test

Falcon Genomics, Inc. has moved as of April 15th 2013.

Please Note our new address: 2661 Clearview Road, #1, Allison Park, PA 15101.  



The goal of Falcon Genomics, Inc. is to provide cutting edge technologies for the accurate diagnosis of cancer patients and the personalized formulation of therapeutic strategies.

Technology Platform
Falcon Genomics' patented technology platform, the Cancer BioChip System (CBCS™)identifies, in a high-throughput three-dimensional fashion, compounds that are required for anchorage-independent growth of patient cells, a hallmark of cellular transformation. Potential compounds include silencing RNA libraries that contain inhibitors for every gene in the human genome.

Technology Applications

The CBCS™can be initially used for high-throughput cancer therapeutic target identification and validation. Through future clinical trials, the CBCS™ can be developed into a diagnostic tool that can be used to guide patient-specific cancer therapies.

Recent News

July 29, 2014

Dr. Rula Abbud-Antaki receives 2 awards at the AACC 2014 Annual Meeting and Clinical Lab Expo for her poster presentation on the Falcon Breast Cancer Test, titled: "Identification of four molecular subclasses of Luminal Breast Cancer with Different likelihood of recurrence and response to Tamoxifen".

May 17, 2013
Falcon Genomics, Inc. receives notice of allowance for its Canadian Patent Application # 2,593,494.

September 28,2012

Falcon Genomics, Inc. press release.

September 26, 2012

Publication of Cancer BioChip article in PLOS ONE.  

Marhefka JN, Abbud-Antaki RA (2012) Validation of the Cancer BioChip System as a 3D siRNA Screening Tool for Breast Cancer Targets.

May 29, 2012

Acceptance for publication in Hormones and Cancer of Cancer BioChip manuscript.  

Abbud-Antaki RA, Marhefka JN, DeLuca AL, Zuromski MP (2012) The Cancer BioChip System: A functional genomic assay for anchorage-independent three-dimensional breast cancer cell growth. Hormones & Cancer, accepted.

December 1, 2011

Falcon Genomics, Inc. receives notice of allowance for its US Patent Application # 11/772,411.

October 6-7, 2011

Falcon Genomics, Inc. reports on the screening power of its Test Cancer BioChip in a poster titled: "Use of the Cancer Biochip System as a Tool for Identifying Therapeutic Targets in Personalizing Breast Cancer Treatment" at the Academic Screening Workshop, Bridgewater, NJ.

June 28, 2011

Dr. Rula Abbud-Antaki presents Falcon Genomics' Company Presentation at BIO 2011, Washington, DC

Falcon Genomics, Inc. announces opening of its gene expression profiling service.

Pharmaceutical companies and research institutions seeking a rapid and efficient platform for the identification of cancer targets in a setting that mimics the in-vivo milieu.


Please contact Dr. Rula Abbud-Antaki for further information:


2661 Clearview Road, Suite # 1, Allison Park, PA 15101, Phone: 412-334-9240, e-mail:

 Copyright © 2007 Falcon Genomics, Inc. All rights reserved.